company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q3,2010-07-01,2010-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,7628000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7628000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,109000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,547000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1117000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,9401000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,9401000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-44000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-5000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,550000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q3,2010-07-01,2010-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,501000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,501000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,55000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,55000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,55000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,34000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q3,2010-07-01,2010-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,9991000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q3,2010-07-01,2010-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,206000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3780000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3780000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,238000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,671000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4340000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,349000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,349000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-28000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3120000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,7283000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q4,2010-10-01,2010-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,4135000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,4135000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,2500000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,293000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2793000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2793000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,43000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q4,2010-10-01,2010-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,7320000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q4,2010-10-01,2010-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,250000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q1,2011-01-01,2011-03-31,2013-04-01 17:05:21+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3849000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q1,2011-01-01,2011-03-31,2013-04-01 17:05:21+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3849000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q1,2011-01-01,2011-03-31,2013-04-01 17:05:21+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,83000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q1,2011-01-01,2011-03-31,2013-04-01 17:05:21+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,525000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q1,2011-01-01,2011-03-31,2013-04-01 17:05:21+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,10141000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q1,2011-01-01,2011-03-31,2013-04-01 17:05:21+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,14598000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q1,2011-01-01,2011-03-31,2013-04-01 17:05:21+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,14598000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q1,2011-01-01,2011-03-31,2013-04-01 17:05:21+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-12000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q1,2011-01-01,2011-03-31,2013-04-01 17:05:21+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-765000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q1,2011-01-01,2011-03-31,2013-04-01 17:05:21+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,3125000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q1,2011-01-01,2011-03-31,2013-04-01 17:05:21+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,2348000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q1,2011-01-01,2011-03-31,2013-04-01 17:05:21+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,2348000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q1,2011-01-01,2011-03-31,2013-04-01 17:05:21+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,106000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q1,2011-01-01,2011-03-31,2013-04-01 17:05:21+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,106000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q1,2011-01-01,2011-03-31,2013-04-01 17:05:21+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,106000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q1,2011-01-01,2011-03-31,2013-04-01 17:05:21+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,31000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q1,2011-01-01,2011-03-31,2013-04-01 17:05:21+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,17083000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q1,2011-01-01,2011-03-31,2013-04-01 17:05:21+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,227000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q2,2011-04-01,2011-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1891000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1891000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,834000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,724000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-9367000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5918000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5918000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-266000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-21257000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-815000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q2,2011-04-01,2011-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-22338000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-22338000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,5202000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5202000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5202000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,92000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q2,2011-04-01,2011-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-22962000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q2,2011-04-01,2011-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,250000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q3,2011-07-01,2011-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,10832000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,10832000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,994000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-542000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-15854000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4570000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4570000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-280000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,600000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q3,2011-07-01,2011-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,320000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,320000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,711000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,711000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,711000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,22000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q3,2011-07-01,2011-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3517000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q3,2011-07-01,2011-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,290000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,11550000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,11550000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1031000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2401000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,10363000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,25345000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,25345000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-128000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,1000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,957000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q4,2011-10-01,2011-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,830000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,830000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-3495000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,303000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-3192000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-3192000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,50000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q4,2011-10-01,2011-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,23033000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q4,2011-10-01,2011-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,335000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q1,2012-01-01,2012-03-31,2013-08-09 06:07:12+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,9665000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q1,2012-01-01,2012-03-31,2013-08-09 06:07:12+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,9665000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q1,2012-01-01,2012-03-31,2013-08-09 06:07:12+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1046000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q1,2012-01-01,2012-03-31,2013-08-09 06:07:12+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q1,2012-01-01,2012-03-31,2013-08-09 06:07:12+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1464000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q1,2012-01-01,2012-03-31,2013-08-09 06:07:12+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,9253000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q1,2012-01-01,2012-03-31,2013-08-09 06:07:12+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,9253000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q1,2012-01-01,2012-03-31,2013-08-09 06:07:12+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-754000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q1,2012-01-01,2012-03-31,2013-08-09 06:07:12+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-754000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q1,2012-01-01,2012-03-31,2013-08-09 06:07:12+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-754000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q1,2012-01-01,2012-03-31,2013-08-09 06:07:12+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1118000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q1,2012-01-01,2012-03-31,2013-08-09 06:07:12+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,408000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q1,2012-01-01,2012-03-31,2013-08-09 06:07:12+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-710000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q1,2012-01-01,2012-03-31,2013-08-09 06:07:12+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-710000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q1,2012-01-01,2012-03-31,2013-08-09 06:07:12+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,28000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q1,2012-01-01,2012-03-31,2013-08-09 06:07:12+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,7817000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q2,2012-04-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,11229000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,11229000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1098000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-57000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,252000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,12522000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,12522000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-110000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q2,2012-04-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-110000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-110000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-7775000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2454000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-5321000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-5321000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-12000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q2,2012-04-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,7079000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q3,2012-07-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13162000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13162000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1102000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,31118000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,119000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,19177000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,19177000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-172000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q3,2012-07-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-172000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-172000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-4800000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-9572000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,388000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-13984000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-13984000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-28000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q3,2012-07-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,4993000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1888000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1888000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,203000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,15558000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-15080000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2569000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2569000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-92000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-75000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q4,2012-10-01,2012-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-167000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-167000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-6371000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1445000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,242000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-4684000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-4684000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-33000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q4,2012-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2315000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q4,2012-10-01,2012-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1893000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:14+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4203000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:14+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4203000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:14+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,202000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:14+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1019000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:14+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,5507000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:14+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,10931000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:14+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,10931000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:14+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-41000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:14+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-41000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:14+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-41000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:14+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-2500000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:14+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,567000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:14+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,104000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:14+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1829000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:14+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1829000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:14+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,16000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:14+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,9077000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1983000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1983000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,211000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1244000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-18051000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-18579000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-18579000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-46000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-46000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-46000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,602000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,603000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,603000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-17000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-18039000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,8708000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8708000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,232000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,215000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,10334000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,19489000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,19489000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-50000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,379000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,329000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,329000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2027000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-7342000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,2299000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,942000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-6128000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-6128000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,126000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,13816000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,36000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,36000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,215000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2295000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4885000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-2339000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-2339000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-187000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-187000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-187000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-8000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-2677000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1629000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,57000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-999000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-999000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,246000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3279000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q4,2013-10-01,2013-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,2237000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:43:03+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4134000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:43:03+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4134000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:43:03+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,207000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:43:03+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,897000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:43:03+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1121000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:43:03+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4117000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:43:03+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4117000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:43:03+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-111000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:43:03+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-111000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:43:03+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-111000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:43:03+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-2569000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:43:03+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,248000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:43:03+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2321000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:43:03+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2321000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:43:03+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-18000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:43:03+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1667000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,9640000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,9640000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,224000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1168000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4538000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,6494000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,6494000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-360000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-360000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-360000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1616000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-6021000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1030000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-6607000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-6607000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-9000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-482000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,7915000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7915000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,221000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1551000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,6156000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,15843000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,15843000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-594000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-2501000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3095000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3095000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-3000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-5589000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2711000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2881000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2881000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-24000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,9843000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3519000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3519000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,200000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1974000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4538000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1155000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1155000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-387000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-2250000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2637000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2637000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-10221000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1225000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-8997000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-8997000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-124000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-10603000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q4,2014-10-01,2014-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,944000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 13:29:34+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,8962000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 13:29:34+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8962000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 13:29:34+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,231000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 13:29:34+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1348000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 13:29:34+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1754000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 13:29:34+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,12295000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 13:29:34+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,12295000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 13:29:34+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-808000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 13:29:34+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-808000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 13:29:34+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-808000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 13:29:34+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-2737000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 13:29:34+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1007000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 13:29:34+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1730000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 13:29:34+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1730000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 13:29:34+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,51000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 13:29:34+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,9808000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4022000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4022000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,288000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1271000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,7003000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4540000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4540000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-263000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-7250000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-7513000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-7513000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-2515000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,3425000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-1007000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-97000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-97000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,8000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3062000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,11979000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,11979000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,283000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1361000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-92000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,13531000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,13531000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-81000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,75000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-6000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-6000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-7559000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,271000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-7288000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-7288000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,13000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,6250000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,12544000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,12544000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,129000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1005000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-11537000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2141000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2141000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-683000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-683000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-683000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-3696000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,4392000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,696000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,696000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,25000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2179000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q4,2015-10-01,2015-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1509000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:30:42+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,7864000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:30:42+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7864000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:30:42+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,249000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:30:42+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1293000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:30:42+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3552000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:30:42+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,12958000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:30:42+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,12958000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:30:42+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-20000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:30:42+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-20000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:30:42+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-20000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:30:42+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,386000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:30:42+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,386000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:30:42+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,386000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:30:42+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-38000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:30:42+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,13286000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,6338000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6338000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,244000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1211000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1626000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,6167000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,6167000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-34000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-34000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-34000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-2888000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-386000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-3274000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-3274000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,61000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2920000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,10116000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,10116000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,244000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2107000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-635000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,11832000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,11832000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-87000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-2718000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2805000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2805000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,2888000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,610000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3498000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3498000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-21000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,12504000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,6411000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6411000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,248000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2047000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5136000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3570000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3570000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-507000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-507000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-507000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-610000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1858000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1248000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1248000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-29000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q4,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,4282000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q4,2016-10-01,2016-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1794000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 16:30:42+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,14596000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 16:30:42+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,14596000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 16:30:42+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,246000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 16:30:42+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1612000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 16:30:42+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-10819000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 16:30:42+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,5635000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 16:30:42+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,5635000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 16:30:42+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-65000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 16:30:42+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-65000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 16:30:42+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-65000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 16:30:42+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1343000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 16:30:42+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1343000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 16:30:42+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1343000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 16:30:42+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,38000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 16:30:42+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,6951000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,12192000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,12192000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,268000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1959000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,285000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,14704000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,14704000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-609000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-609000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-609000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1840000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1840000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1840000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,47000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,15982000.0
